Filing Flows › Tarsus Pharmaceuticals (TARS) › How it makes money
How Tarsus Pharmaceuticals (TARS) makes money
Tarsus Pharmaceuticals (TARS) made $195M of revenue in the third quarter 2026 (Q3 2026), +64% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $195M | 100.0% |
| Income tax | $4.6M | 2.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $195M | +64% |
| Q2 2026 | $174M | +69% |
| Q1 2026 | $162M | +107% |
| Q4 2025 | $152M | +128% |
| Q3 2025 | $119M | +147% |
| Q2 2025 | $103M | +152% |
| Q1 2025 | $78.3M | +184% |
From Tarsus Pharmaceuticals' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Tarsus Pharmaceuticals make money?
Tarsus Pharmaceuticals (TARS) made $195M of revenue in the third quarter 2026 (Q3 2026), +64% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.